Stories of hope, foundation updates, and news from the bone marrow donation community.
Gene therapy for sickle cell disease was approved three years ago and remains out of reach for most patients. A published cost-effectiveness analysis found stem cell transplantation the more cost-effective option for adults. Here is how the two compare, ahead of Sickle Cell Awareness Month.
Reauthorization of the C.W. Bill Young Cell Transplantation Program cleared the House in July. Two weeks later, both the House-passed bill and the Senate companion are parked on the Senate calendar. Here is exactly where things stand, and what still has to happen.
Blood and marrow are on the standards in every science curriculum, and almost nothing exists to teach them well. We built sixteen lessons across four grade bands — K-2, 3-5, 6-8 and 9-12 — and they are free.
Thinking about hosting a bone marrow donor registration drive? Here is a warm, practical walkthrough: choose your audience and venue, help people find the right registry for their country, keep the sign-up moment simple, and follow up without pressure.
Bone marrow, PBSC, and cord blood are three sources of the same blood-forming stem cells. Here is how each one works, in plain English, and why the patient's transplant team, not the donor, decides which is requested.
NMDP passed a milestone: roughly 150,000 lives reached through the federally funded C.W. Bill Young Cell Transplantation Program since 1987. Large round numbers are easy to print and hard to feel. Here is what this one is actually counting.
Joining a registry can make you available as a potential match for a patient who needs a transplant. JBF helps you find the official registry that serves your country.